
Loading, please wait...

Loading, please wait...

Recent clinical evidence highlights that ACS and AKI risk represents a critical concern for medical professionals managing cardiovascular emergencies. Patients presenting with acute coronary syndrome often exhibit signs of renal impairment that can complicate their treatment course. A massive study involving over 21,000 patients recently explored the prevalence and long-term prognosis of this dual diagnosis. Consequently, the research findings clarify the timing and impact of kidney injury in these clinical scenarios.
The investigators utilized the serum creatinine criteria from the Kidney Disease: Improving Global Outcomes (KDIGO) guidelines to detect AKI episodes. Interestingly, the data revealed that ACS independently associates with an increased risk of kidney injury specifically at the time of admission. The multi-variable analysis showed an adjusted odds ratio of 2.327. However, the study also found that ACS does not significantly increase the risk of developing new AKI during the remainder of the hospital stay. Therefore, the initial assessment phase remains the most crucial period for detection.
Furthermore, the team examined recovery rates and mortality at 30-day and 90-day intervals. Because AKI recovery directly influences patient outcomes, clinicians must prioritize early intervention strategies. Additionally, the results suggest that while the association is strongest upon entry, the overall burden of AKI in ACS patients remains a major contributor to inpatient morbidity. Moreover, integrating renal monitoring into standard protocols can help doctors identify high-risk individuals sooner.
Patients often arrive with hemodynamic instability or acute stress that impairs renal perfusion. This initial physiological shock likely triggers the AKI detected at the time of admission.
Physicians should follow KDIGO guidelines, which recommend tracking changes in serum creatinine levels. Monitoring urine output also provides vital data for staging the severity of the injury.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional relationship. Always seek the advice of a qualified healthcare provider regarding any medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Szeto CC et al. Acute coronary syndrome is associated with acute kidney injury on admission but not during hospital stay. Ren Fail. 2026 Dec undefined. doi: 10.1080/0886022X.2026.2666698. PMID: 42092296.
Kidney Disease: Improving Global Outcomes (KDIGO) AKI Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Inter., Suppl. 2012; 2: 1–138.
Apostolovic S et al. Acute kidney injury in patients with acute coronary syndrome - risk profile. Oxford Academic. 2024 May.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A study of 21,328 patients reveals that Acute Coronary Syndrome (ACS) significantly increases the risk of AKI on admission, though not during the hospital s...
5 months ago

Co-administering antiseizure medications and DOACs frequently causes pharmacokinetic interactions, subtherapeutic drug levels, and thromboembolic failures. This review highlights enzyme induction risks, unpredictable outcomes with levetiracetam, and the vital role of therapeutic drug monitoring.
Today

Demanding exhaustive hormonal profiling can inadvertently discourage clinical studies involving females. Methodological standards must align with the specific scientific question to expand, not restrict, equitable evidence for women.
Today

An elderly man with partially repaired Tetralogy of Fallot presented with STEMI caused by coronary embolism rather than atherosclerosis. Successful treatment with sustained mechanical aspiration thrombectomy underscores the vital need for high clinical vigilance in adult congenital heart disease.
Today

A comparative review of tension band wiring and intramedullary screw fixation in thumb metacarpophalangeal arthrodesis, evaluating union rates, hardware complications, and clinical outcomes.
Today

Following regulatory scrutiny from FSSAI regarding promotional representations and lean muscle preservation claims, Dr. Reddy's Laboratories and Nestlé Health Science are currently reviewing the branding and marketing strategy for their joint nutritional supplement Celevida GLP+.
Today